|
|
C M Weyand, A D Wagner, J Björnsson, J J Goronzy
J Clin Invest. 1996;
98(7):1642
doi:10.1172/JCI118959
Abstract |
Full text
| PDF

E
nd organ ischemia, fragmentation of elastic membranes, and aneurysm formation in patients with giant cell vasculitis results from an inflammation destroying the mural layers of large and medium sized arteries. Although the inflammatory infiltrate extends through all layers of the affected blood vessel, the most pronounced changes involve the intima and the internal elastic lamina. Analysis of the functional profile of tissue infiltrating CD68+ cells demonstrates that different subsets of macrophages can be distinguished. TGFbeta1-expressing CD68+ cells coproduce IL-1beta and IL-6, are negative for inducible nitric oxide synthase (iNOS), and exhibit a strong preference for localization in the adventitia. The adventitial homing of TGFbeta1+ CD68+ cells places them in the vicinity of IFN-gamma secreting CD4+ T cells which also accumulate in the exterior layer of the artery. Conversely, iNOS expressing CD68+ cells are negative for TGFbeta and are almost exclusively found in the intimal layer of the inflamed artery. The intimal-medial junction is the preferred site for 72-kD collagenase expressing CD68+ cells. Thus, TGFbeta1-producing macrophages colocalize with activated CD4+ T cells and home to an area of inflammation which is distant from the site of tissue damage but critical in regulating cellular influx, suggesting that TGFbeta1 functions as a proinflammatory mediator in this disease. iNOS- and 72-kD collagenase-producing macrophages accumulate at the center of pathology implying a role of these products in tissue destruction. These data indicate that the microenvironment controls the topographical arrangement as well as the functional commitment of macrophages.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(44)
| Title and authors |
Publication |
Year |
Giant Cell Arteritis: A Review of Classification, Pathophysiology, Geoepidemiology and Treatment
Andrea T. Borchers, M. Eric Gershwin
|
Autoimmunity Reviews
|
2012 |
IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis
Cornelia M Weyand, Brian R Younge, Jörg J Goronzy
|
Current Opinion in Rheumatology
|
2011 |
Ocular Disease
Lynn K Gordon
|
Ocular Disease
|
2010 |
Aortic involvement in giant cell arteritis
F. Martínez-Valle, R. Solans-Laqué, J. Bosch-Gil, M. Vilardell-Tarrés
|
Autoimmunity Reviews
|
2010 |
Current understanding and management of giant cell arteritis and polymyalgia rheumatica
Parasar Ghosh, Frances A Borg, Bhaskar Dasgupta
|
Expert Rev Clin Immunol
|
2010 |
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
Kim-Heang Ly, Alexis Régent, Mathieu C. Tamby, Luc Mouthon
|
Autoimmunity Reviews
|
2010 |
Giant cell arteritis
S.S.L. Chew, N.M. Kerr, H.V. Danesh-Meyer
|
Journal of Clinical Neuroscience
|
2009 |
Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 Genotype with polymyalgia rheumatica
Lorena Alvarez-Rodriguez, Eugenio Carrasco-Marin, Marcos Lopez-Hoyos, Cristina Mata, Lorena Fernandez-Prieto, Maria Ruiz-Soto, Jaime Calvo, Vicente Rodriguez-Valverde, Teresa Ruiz, Ricardo Blanco, Alfonso Corrales, Victor Manuel Martinez-Taboada
|
Human Immunology
|
2009 |
Recent Advances in the Immunopathology of Giant Cell Arteritis
Kenneth K. Chang, Joseph F. Rizzo
|
International Ophthalmology Clinics
|
2009 |
Pathogenese der Vaskulitis mittlerer und großer Gefäße
C.M. Weyand, J.J. Goronzy
|
Z. Rheumatol.
|
2009 |
|